Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Saul Campos Gomez"'
Autor:
Debu Tripathy, Yan Ji, Arunava Chakravartty, Yongyu Wang, Craig Wang, Nadia Solovieff, Claudia Gasch, Ruth O'Regan, Nagi El-Saghir, Sherko Kuemmel, Young-Hyuck Im, Michelino De Laurentiis, Paul Wheatley-Price, K. Govind Babu, Kyung Hae Jung, Rafael Villanueva Vazquez, Saul Campos-Gomez, Keun Seok Lee, Joohyuk Sohn, Louis Chow, Sara Hurvitz, Nadia Harbeck, Fatima Cardoso, Aditya Bardia, Fabio Franke, Marco Colleoni, Seock-Ah Im, Yen-Shen Lu
Supplementary Figure from Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247e6fe0c708a74fb8bd422fc255b88e
https://doi.org/10.1158/1078-0432.22487360
https://doi.org/10.1158/1078-0432.22487360
Autor:
Debu Tripathy, Yan Ji, Arunava Chakravartty, Yongyu Wang, Craig Wang, Nadia Solovieff, Claudia Gasch, Ruth O'Regan, Nagi El-Saghir, Sherko Kuemmel, Young-Hyuck Im, Michelino De Laurentiis, Paul Wheatley-Price, K. Govind Babu, Kyung Hae Jung, Rafael Villanueva Vazquez, Saul Campos-Gomez, Keun Seok Lee, Joohyuk Sohn, Louis Chow, Sara Hurvitz, Nadia Harbeck, Fatima Cardoso, Aditya Bardia, Fabio Franke, Marco Colleoni, Seock-Ah Im, Yen-Shen Lu
Purpose:Ribociclib plus endocrine therapy (ET) demonstrated a statistically significant progression-free survival and overall survival (OS) benefit in the phase III MONALEESA-7 trial of pre-/perimenopausal patients with hormone receptor (HR)-positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304edc6d2f98864829bedb6942c99952
https://doi.org/10.1158/1078-0432.c.6532502.v1
https://doi.org/10.1158/1078-0432.c.6532502.v1
Autor:
Debu Tripathy, Yan Ji, Arunava Chakravartty, Yongyu Wang, Craig Wang, Nadia Solovieff, Claudia Gasch, Ruth O'Regan, Nagi El-Saghir, Sherko Kuemmel, Young-Hyuck Im, Michelino De Laurentiis, Paul Wheatley-Price, K. Govind Babu, Kyung Hae Jung, Rafael Villanueva Vazquez, Saul Campos-Gomez, Keun Seok Lee, Joohyuk Sohn, Louis Chow, Sara Hurvitz, Nadia Harbeck, Fatima Cardoso, Aditya Bardia, Fabio Franke, Marco Colleoni, Seock-Ah Im, Yen-Shen Lu
Supplementary Table from Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13fa487cd5dbbb5bcb14d192dffde384
https://doi.org/10.1158/1078-0432.22487348.v1
https://doi.org/10.1158/1078-0432.22487348.v1
Autor:
Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Fatima Cardoso, Nadia Harbeck, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee, Saul Campos-Gomez, Rafael Villanueva Vazquez, Kyung Hae Jung, K. Govind Babu, Paul Wheatley-Price, Michelino De Laurentiis, Young-Hyuck Im, Sherko Kuemmel, Nagi El-Saghir, Ruth O'Regan, Claudia Gasch, Nadia Solovieff, Craig Wang, Yongyu Wang, Arunava Chakravartty, Yan Ji, Debu Tripathy
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 5
Purpose: Ribociclib plus endocrine therapy (ET) demonstrated a statistically significant progression-free survival and overall survival (OS) benefit in the phase III MONALEESA-7 trial of pre-/perimenopausal patients with hormone receptor (HR)-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff6fc5fc3fed4998874ffed5668fb72a
https://escholarship.org/uc/item/6hf2w93b
https://escholarship.org/uc/item/6hf2w93b
Publikováno v:
Journal of adolescent and young adult oncology. 11(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6011196edeaa42f1c85137219d187af4
https://pubmed.ncbi.nlm.nih.gov/34936493
https://pubmed.ncbi.nlm.nih.gov/34936493
Autor:
Saul Campos-Gomez
Publikováno v:
Journal of Clinical Oncology. 40:e16549-e16549
e16549 Background: Treatment of Urothelial Cancer (UC) is rapidly evolving with innovative biomarker-based approaches. Alterations in the gene encoding fibroblast growth factor receptor (FGFR) are frequent in UC and are an emerging focus for targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8f55eb9ef8996f334532e5b75cf4b8a
https://doi.org/10.1200/jco.2022.40.16_suppl.e16549
https://doi.org/10.1200/jco.2022.40.16_suppl.e16549
Autor:
Marco Colleoni, Yen-Shen Lu, Gareth Hughes, Seock-Ah Im, Nadia Harbeck, Joohyuk Sohn, Louis W.C. Chow, Sara A. Hurvitz, Saul Campos Gomez, Keun Seok Lee, Tetiana Taran, Aditya Bardia, Fabio Franke, Rafael Jacinto Villanueva, Arunava Chakravartty, Karen Rodriguez-Lorenc, Debu Tripathy, Ioannis Gounaris, Kyung Hae Jung
Publikováno v:
Journal of Clinical Oncology. 37:LBA1008-LBA1008
LBA1008 Background: The phase III MONALEESA-7 study (NCT02278120) is the first dedicated trial of endocrine therapy (ET) ± a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor in premenopausal patients (pts) with hormone receptor–positive (HR+)/HER2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b20ddf53b206a39452ec666a72c84a84
https://doi.org/10.1200/jco.2019.37.18_suppl.lba1008
https://doi.org/10.1200/jco.2019.37.18_suppl.lba1008
Autor:
Marco Colleoni, Debu Tripathy, Paul Wheatley-Price, Wei He, Naveen Babbar, Louis W.C. Chow, Fabio Franke, Sherko Kuemmel, Nadia Harbeck, Saul Campos Gomez, Karen Rodriguez-Lorenc, Aditya Bardia, Seock-Ah Im, Sara A. Hurvitz, Fei Su, Kyung Hae Jung, Tetiana Taran, Yen-Shen Lu
Publikováno v:
Journal of Clinical Oncology. 37:1018-1018
1018 Background: The Phase III MONALEESA-7 study (NCT02278120) is the first dedicated trial of endocrine therapy (ET) ± a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor in premenopausal patients (pts) with hormone receptor–positive (HR+)/human epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b519879aa6ee47f93826b41e6190afb2
https://doi.org/10.1200/jco.2019.37.15_suppl.1018
https://doi.org/10.1200/jco.2019.37.15_suppl.1018
Autor:
Federica Martorana, Milena Sant, Herman A. Perroud, Serena Di Cosimo, Alessandro Marco Minisini, Debora Basile, Lorenzo Gerratana, Fabio Puglisi, Karen Angelica Campos Gomez, Secondo Folli, N. Antone, Paolo Vigneri, Andrei Cismaru, Grazia Arpino, Irene De Santo, Giulia Galli, Marika Cinausero, Alexandru Eniu, Gianpiero Fasola, Saul Campos Gomez
Publikováno v:
Journal of Clinical Oncology. 36:e12629-e12629
e12629Background: Little is known about the timing-related effects of the interval between the last neoadjuvant CT administration and surgery (CTTS) in patients (pts) with early breast cancer (BC)....
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ca2991eef7383bf0615ab9e0a8068ec
https://doi.org/10.1200/jco.2018.36.15_suppl.e12629
https://doi.org/10.1200/jco.2018.36.15_suppl.e12629
Autor:
Juan Valdes Andrade, A. Stoian, Laura Pop, Saul Campos Gomez, Hicham Ouchene, Guillermo Pacheco-Cuéllar, Karen Angelica Campos Gomez, Eleonora Dronca, Marjolijn J. L. Ligtenberg, Andrea Onisim, N. Antone, Alexandru Eniu, R. Matei, R. Eniu, Olivia Rotaru
Publikováno v:
Publons
e13572Background: Breast cancer (BC) is the most common malignancy in women with 6.6% of cases diagnosed in young women below the age of 40. Although there are significant similarities in demograph...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b437ccf04b94988b24ef82a0380eca
https://doi.org/10.1200/jco.2018.36.15_suppl.e13572
https://doi.org/10.1200/jco.2018.36.15_suppl.e13572